Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 14Non-Muscle Invasive Bladder Neoplasms 10Colorectal Neoplasms 7Appendiceal Neoplasms 6Anus Neoplasms 6Peritoneal Neoplasms 5Carcinoma, Transitional Cell 5Stomach Neoplasms 2Pseudomyxoma Peritonei 2Ovarian Neoplasms 2Uterine Neoplasms 1Urothelial Carcinoma of the Bladder 1Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Urinary Bladder Diseases 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Pleural Neoplasms 1Peritoneal Diseases 1Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1Necrosis 1Nasopharyngeal Carcinoma 1Mediastinal Neoplasms 1Male Urogenital Diseases 1

Interventions

Mitomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Peritoneal Diseases × Mitomycin × 1 year × Clear all
NCT07487168 2026-05-15

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Not yet recruiting
24 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡